npx2011.htm

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM N-PX
 
                                                                                                                                   Investment Company Act File Number: 811-22299
   
RENN Global Entrepreneurs Fund, Inc.
 
 
                                                                                                            8080 N. Central Expressway, Suite 210,  LB - 59         Dallas, Texas 75206-1857
                                                                                                                     (Address of Principal Executive Offices)                                (Zip Code)
 
  Russell G. Cleveland
   8080 N. Central Expressway, Suite 210, LB-59
  Dallas, Texas 75206-1857
                                                                                                                                            (Name and Address of Agent for Service)
 
                                                                                                                                       Registrant’s telephone number:         214-891-8294
                                                                                                                                       Date of Fiscal Year-End:                      12/31/2010
                                                                                                                                      Date of reporting period:             7/1/2010 – 6/30/2011

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form-N-PX, and the Commission will make this information public.  
 
Item 1:  Proxy Voting Record.

Disclosed is the following information for each matter relating to a portfolio security considered at any shareholder meeting held during the period covered by the report and with respect to which the registrant was entitled to vote:
 
Bovie Medical Corporation
Ticker:                BVX                                   CUSIP/CINS ID:   10211F100
Meeting Date:   December 9, 2010            Meeting Type:     Annual
Record Date:     October 27, 2010
 
Proposal
Recommend
Vote Cast
Sponsor
            
1.1  Elect Director Andrew Makrides
For
For
Management
            
1.2  Elect Director J. Robert Saron
For
For
Management
            
1.3 Elect Director Michael Norman
For
For
Management
            
1.4 Elect Director George W. Kromer, Jr.
For
For
Management
            
1.5  Elect Director August Lentricchia
For
For
Management
            
1.6  Elect Director Steven MaClaren
For
For
Management
            
1.7  Elect Director Peter Pardoll
For
For
Management
            
1.8  Elect Director Geogory A. Konesky
For
For
Management
            
  2.  Ratify the selection of Kingery & Crouse
  P.A as the company's independent public accountants for the year ending December 31, 2010.
For
For
Management
            
           
           
China Jo-Jo Drugstore, Inc.
Ticker:                   CJJD                                  CUSIP/CINS ID:  16949A206
Meeting Date:      November 2, 2010           Meeting Type:    Annual
Record Date:        October 4 , 2010
 
          
Proposal
 Recommend
Vote Cast
Sponsor
1.1  Elect Director Lei Liu
For
For
 Management
1.2  Elect Director Li Qi
For
For
 Management
1.3  Elect Director Chong'an Jin
For
For
 Management
1.4  Elect Director Shike Zhu
For
For
 Management
1.5  Elect Director Marc Thomas Serrio
For
For
 Management
1.6  Elect Director Bowen Zhao                           For               For          Management
1.7  Elect Director Yuehai Ke                           For               For          Management
1.8  Elect Director Shuizhen Wu                           For                  For          Management
1.9  Elect Director Xiaomeng Yu                           For               For          Management
 2.  Ratify the appointment of Frazer Frost, LLP as the Company's registered independent public accountants for the fiscal year ending March 31, 2011.
 For
For
 Management
 3.  Approve the China Jo-Jo Drugstores, Inc. 2010 Equity incentive Plan (The "Plan").
 For
For
 Management
4.  In his discretion, upon the transaction of any other matters which may properly come before the meeting or any adjournment thereof.                          For               For          Management
 
 
 
 
 
 
 
 
 
COGO Group Inc.
Ticker:                   COGO                                  CUSIP/CINS ID:  192448108
Meeting Date:      December 22, 2010           Meeting Type:     Annual
Record Date:        November 3, 2010
 
          
Proposal
 Recommend
Vote Cast
Sponsor
1.1  Elect Director Q.Y. Ma
For
For
Management
1.2  Elect Director JP Gan
For
For
Management
1.3  Elect Director George Mao
For
For
Management
1.4  Elect Director Jeffery Kang
For
For
Management
1.5  Elect Director Frank Zheng
For
For
Management
 2.  Ratification of the appointment of  KPMG as independent auditors of the company for the fiscal year ending December 31, 2010.
For
For
Management
 
 
Orient Paper Inc.
Ticker:                   ONP                                   CUSIP/CINS ID:  000135190
Meeting Date:      August 21, 2010              Meeting Type:    Annual
Record Date:        June 25, 2010

Proposal
 Recommend
Vote Cast
Sponsor
1.1  Elect Director Zhenyong Liu
For
For
Management
1.2  Elect Director Drew Bernstein
For
For
Management
1.3  Elect Director Wenbing Christopher Wang
For
For
Management
1.4  Elect Director Fuzeng Liu
For
For
Management
1.5  Elect Director Zhaofang Wang
For
For
Management
 2.  To approve an amendment to the Company's certificate of incorporation (the "Certificate of Incorporation") to authorize the classification of the Board into two classes with staggered terms.
For
For
Management
 3.  To ratify the appointment of BDO Limited as our independent registered public accounting firm for our fiscal year ending December 31, 2010.
For
For
Management
4.  To act on such other matters as may properly come before the meeting or any adjournment or adjournments thereof.                            For               For           Management
 
 
PHC, Inc.
Ticker:                   PHC                                     CUSIP/CINS ID:   693315103
Meeting Date:      December 16, 2010           Meeting Type:     Annual
Record Date:        October 18, 2010

Proposal
 Recommend
Vote Cast
Sponsor
1.1  Elect Director Donald E. Robar
For
For
Management
1.2  Elect Director Howard W. Phillips
For
For
Management
 2.  To consider and vote upon a proposed amendment to increase
 the number of shares of Class A common stock available for
issuance under the 2004 non-employee director stock option plan
 from 350,000 to 950,000 shares.
For
For
Management
3.  To consider and vote upon a proposed amendment to increase
the number of shares of Class A common stock available for
 issuance under the 2003 stock purchase and option plan
 from 1,900,000 to 2,400,000 shares.
For
For
Management
4.  To ratify the selection by the Board of Directors of
 BDO USA, LLP as the company's independent registered
 public accounting firm for the 2011 fiscal year.
For
For
Management

 
Points International Ltd.
Ticker:                  PTSEF                                CUSIP/CINS ID:   730843109
Meeting Date:    October 26, 2010              Meeting Type:      Special 
Record Date:      September 20, 2010

Proposal
 Recommend
Vote Cast
Sponsor
1. The special resolution approving an amendment to Points International LTD.'s articles of continuance to consolidate its issued and outstanding common shares on the basis of a ratio within the range of one post-consolidation common share for every eight pre-consolidation shares to one post-consolidation  common share for every twelve pre-consolidation common shares, with the ratio to be selected and implemented by the Board of Directors in its sole discretion, if at all, at any time prior to October 26, 2011.
For
For
Management
2. The ordinary resolution approving an amendment to points international LTD.'s incentive stock option plan to increase the maxium number of common shares that may be issued thereunder by an additional 4,500,000 to be implemented by the Board of Directors in its sole discretion, if at all, at any time prior to October 26, 2011.
For
For
Management
 
 
Skystar Bio-Pharmaceutical Company
Ticker:                   SKBI                                     CUSIP/CINS ID:  830884300
Meeting Date:      December 29, 2010             Meeting Type:    Annual
Record Date:        December 1, 2010

Proposal
Recommend
Vote Cast
                      Sponsor
1.1 Elect Director Weibing Lu,
For
For
                  Management
1.2 Elect Director Wei Wen
For
For
                  Management
1.3 Elect Director Mark D. Chen
For
For
                  Management
1.4 Elect Director R. Scott Cramer
For
For
                  Management
1.5 Elect Director Fan Qiang
For
For
                  Management
1.6 Elect Director Chengtun Qu                       For                 For                   Management 
1.7 Elect Director Shouguo Zhao
For
For
                  Management
 2. In his discretion, upon the transaction of any other matters which may properly come before the meeting or any adjournment thereof.
For
For
                  Management

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Registrant:                        RENN Global Entrepreneurs Fund, Inc.
                                            /s/ Russell Cleveland
By:                                    Russell Cleveland
Title:                                 President, CEO & Director
Date:                                 August 15, 2011